Medtronic Reports CE Mark for Engager Transcatheter
February 28, 2013 at 09:03 AM EST
Medtronic, Inc. (NYSE: MDT ) today announced CE (Conformité Européenne) Mark of the Engager Transcatheter Aortic Valve Implantation (TAVI) System with transapical delivery catheter to treat patients with severe aortic stenosis who are at high or extreme risk for surgical aortic valve replacement (SAVR). The new valve demonstrated positive clinical outcomes in its European